This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Brandon University directory, so their courses may be missing. Find their university profile.
Latest papers
Prospective Breast Cancer Biomarkers Identified Using miR-526b-Driven Metabolic Alterations.
Cancer informatics · 2026 · senior author
Investigating the effects of miR-526b and miR-655 on doxorubicin sensitivity in breast cancer.
Scientific reports · 2025 · senior author
Distinct Oxidative Stress Adaptations Driven by the Overexpression of miR-526b, miR-655, and COX-2 in Breast Cancer.
International journal of molecular sciences · 2025 · senior author
Latest funding
- $6,000
Differential Analysis of Doxorubicin Resistant Breast Cancer Cells
CIHR · 2026 · Supervisor
- $6,000
Evaluating the roles of miRNA in metabolic stress responses in breast cancer
CIHR · 2025 · Supervisor
- $6,000
ATP5FA1 as a therapeutic target in breast cancer
CIHR · 2024 · Supervisor
17 publications.
Prospective Breast Cancer Biomarkers Identified Using miR-526b-Driven Metabolic Alterations.
Nault B, Majumder M
Investigating the effects of miR-526b and miR-655 on doxorubicin sensitivity in breast cancer.
Opperman RM, Maiti S, Majumder M
Distinct Oxidative Stress Adaptations Driven by the Overexpression of miR-526b, miR-655, and COX-2 in Breast Cancer.
Opperman RM, Maiti S, Majumder M
miR-526b enhances glucose metabolism in breast cancer cells, an effect reversed by targeting the COX-2/EP4 pathway.
Nault BD, Majumder M
A Prospective Tumour Marker for Breast Cancer: YWHAB and Its Role in Promoting Oncogenic Phenotypes.
Gopaul VL, Winstone L, Gatien BG, Nault BD, Maiti S, Opperman RM, Majumder M
Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.
Feser R, Opperman RM, Nault B, Maiti S, Chen VC, Majumder M
Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer.
Majumder M, Ugwuagbo KC, Maiti S, Lala PK, Brackstone M
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.
De Paz Linares GA, Opperman RM, Majumder M, Lala PK
Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
Gervin E, Shin B, Opperman R, Cullen M, Feser R, Maiti S, Majumder M
miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
Shin B, Feser R, Nault B, Hunter S, Maiti S, Ugwuagbo KC, Majumder M
Differential Analysis of Doxorubicin Resistant Breast Cancer Cells
Principal investigators: Temitope, Morolaoluwa F
Keywords: Breast Cancer; Death; Resistance
Evaluating the roles of miRNA in metabolic stress responses in breast cancer
Principal investigators: Temitope, Morolaoluwa F
Keywords: Antioxidants; Breast Cancer; Cancer; Death; Early Detection; Healthcare; Oxidative Stress; Oxygen Species; Treatment; Tumor
ATP5FA1 as a therapeutic target in breast cancer
Principal investigators: Temitope, Morolaoluwa F
Keywords: Angiogenesis; Cancer; Rna; Tumor Cells; Vascular Endothelial Growth Factors
Canada Research Chair - Tier 2
Principal investigators: Majumder, Mousumi
Keywords: Crc
Molecular Determinants of Vertebrate Vasculature and Development
Principal investigators: Majumder, Mousumi
Keywords: Angiogenesis; Embyionic Developement; EP4; HUVEC; Micro Array; Micro RNA; PGE2; PI3K/Akt; Vasculogenesis; Zebrafish
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Braydon Nault and Mousumi Majumder: 5 shared papers
- Muriel Brackstone and Mousumi Majumder: 2 shared papers
- David Hess and Mousumi Majumder: 2 shared papers
- Muriel Brackstone and David Hess: 1 shared paper
- Biology
- Department: Biology, Chemistry
- Physiology and Pharmacology
- Surgery
Co-authors at Brandon University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.